Home News Levit Green near Texas Medical Center lands first biotech tenant

Levit Green near Texas Medical Center lands first biotech tenant

by admin
0 comment

A Chinese biotech firm has signed on to become the first life sciences company in the highly anticipated Levit Green in Hines, a 53-acre mixed-use life sciences district Under construction Near Texas Medical Center.

Sino Biological, a global biomanufacturing company specializing in the production of antibodies and recombinant proteins, will locate its first US-based manufacturing facility in Levit Green, Hines announced. The Beijing-based company signed a lease for a 10,000-square-foot commercial lab and office in Phase 1 of his Levit Green, being developed by Houston firm Hines and partners his 2ML Real Estate Interests and Harrison Street. Did.

“Our new site in (adjacent to) the Levitt Green masterplan district in the heart of Texas Medical Center in Houston will allow Sino Biological to significantly expand its research services and bioreagent manufacturing capabilities to the United States. ,” said Chief Dr. Rob Burgess. Business manager of Sino Biological.

A while ago: 53-acre life sciences district with lake and restaurants near Texas Medical Center

Sino Biological has a Houston office opening in early 2022 at 10101 Southwest Freeway. A company spokesperson said the new location in Levit Green will be used for product manufacturing and contract research services, while maintaining it as a marketing office. Sino Biological plans to place 20 employees in Levit Green in the third quarter of 2023.

Located on the corner of Dixie Drive and Grand Boulevard, Levit Green is one mile east of the Texas Medical Center campus. However, due to its proximity to TMC, Levit Green’s tenants will have easy access to TMC and a 37-acre biomedical research campus called TMC Helix Park (formerly known as TMC3) under construction nearby. is expected.

Sino Biological will house a five-story, 294,000-square-foot building with a ground-floor restaurant and café with patio seating overlooking an artificial lake. The building is expected to be completed by the end of this year.

A rendering of the lobby space in Building 1 of Levit Green, a 53-acre life sciences district being developed by Hines in partnership with 2ML Real Estate and Harrison Street.


A 5,800-square-foot future fitness center on the first floor features large windows that open onto an outdoor garden near the building’s entrance. The ground floor will also include his 25,000-square-foot incubator space for startups and his 7,000-square-foot conference room that can accommodate hundreds.

Hines also offers two commercial lab and office suites of 11,000 square feet and 7,000 square feet, available for occupancy by summer 2023.

Levit Green could boost efforts by economic developers to foster the rise of life science clusters in Greater Houston. Economic developers are positioning Houston, already the world’s largest medical center and research concentration, as a new center for biotechnology, medical technology and other life sciences, the so-called Third Coast. Boston.

Related: Fujifilm Diosynth Breaks Ground on $300 Million Biotech Plant Near Texas A&M

Houston has fallen well behind East and West Coast powerhouses in recent life sciences talent market top rankings, but Houston nonetheless represents “substantial pockets of talent,” making it one of the leading cities in the life sciences talent cluster. It ranks 13th out of the top 25 markets.nationally analysis It is by real estate company CBRE.

Of the $870 million in grants awarded to Texas by the National Institutes of Health in 2021, the Houston area will receive more than half, according to research by real estate firm JLL.

Property developers are building about 640,000 square feet of life sciences space, with another million square feet proposed, according to JLL.

JLL represented Levit Green’s developer in lease negotiations with Sino Biological. Tenants represented themselves.

Sino Biological has a subsidiary in Suzhou, China. Taizhou, China; Frankfurt, Germany. The company claims to be the world’s leading provider of mammalian cell-based recombinant proteins, antibodies and related contract research services.

You may also like